TickerFactsScreenerDevelopers

Viridian Therapeutics, Inc.\DE (VRDN) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2013: $209.0K2014: $5.12M2015: $21.23M2016: $22.10M2017: $47.44M2018: $32.61M$32.61M
2013Cash & Equivalents (USD)2018
Fiscal YearCash & EquivalentsChange YoY
2018$32.61M-31.3%
2017$47.44M+114.6%
2016$22.10M+4.1%
2015$21.23M+314.8%
2014$5.12M+2349.3%
2013$209.0K—